Controlled Substance Prescribing and Diversion. Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control

Similar documents
Controlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System

SCRIPTS. South Carolina Reporting & Identification Prescription Tracking System

11/11/2015. MVAs Suicide Firearms Homicide. Where Can I Find A Copy of the PDMP Law? Why Was the Law Established? Why Was the Law Established?

DEA: Combating the Supply

NC General Statutes - Chapter 90 Article 5E 1

AHLA. X. Federal Enforcement of Fraud and Abuse Involving Opioid Abuse and Diversion

Crowe Healthcare Webinar Series

ARKANSAS STATE UNIVERSITY GOVERNING PRINCIPLES FOR THE USE OF CONTROLLED SUBSTANCES IN RESEARCH

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

SWALLOWING THE WRONG PILL Criminal Drug Diversion By Physicians and Other Medical Professionals A Prosecutor s Perspective

Do not open the test booklet prior to being told to do so.

9/5/2011. Outline. 1. Past and Current Trends re: RX Abuse 2. Diversion Methods 3. Regulatory Reporting Requirements 4. Q/A

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Prescription Monitoring Program (PMP)

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

PART 1306 PRESCRIPTIONS. 21 CFR Ch. II ( Edition)

This Chapter Contains:

Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors

Prescribing and Dispensing Drugs

NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.

2016 Dr. Douglas H. Kay CPE Symposium

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Michigan Opioid Legislation Hospital Compliance Checklist

A Bill Regular Session, 2015 SENATE BILL 717

Teaching Objectives Describe the balance a that must be sought in the treatment of pain and the prevention of drug diversion. Discuss regulatory polic

NATIONAL ALLIANCE FOR MODEL STATE DRUG LAWS (NAMSDL) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT-

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

We are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit

Guideline for the Rational Use of Controlled Drugs

Opioids And DEA Compliance

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

UNIVERSITY POLICY. Revised: Contact:

North Carolina, like the rest of the nation, has been experiencing

Model State Electronic Prescription Monitoring Program Legislation

WHAT YOU NEED TO KNOW TO ABOUT AB 474

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

SECTION PRESCRIPTIONS

9/13/2017 DEA WHO WE ARE: Prescription Drug Abuse. American Association of Service Coordinators September 24-27, 2017 Disney s Coronado Springs Resort

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Prescription Drug Abuse National Perspective

Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016

Michigan Automated Prescription System

6/19/2012. Disappearing Drugs. Disappearing Drugs: Protect Yourself from Diversion. Disappearing Drugs: Protect Yourself from Diversion

The Controlled Substances Act: Regulatory Requirements

PHARMACY 543 PHARMACY LAWS & ETHICS MIDTERM EXAMINATION October 29, 1998

Controlled Substances Program. For Academic Units

Opioid Monitoring for Pharmacies: A View from the DEA s Perspective

RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER DRUG DONATION REPOSITORY PROGRAM TABLE OF CONTENTS

C U S T O M E R D R I V E N. B U S I N E S S M I N D E D.

Vermont. Prescribing and Dispensing Profile. Research current through November 2015.

Ahsan U. Rashid, M.D., F.A.C.P.

Prescription Drugs: Issues in Treatment, Supervision and Case Management

Angelman s Inc.

2013 DEA REGULATORY ENFORCEMENT UPDATE

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION HOUSE BILL DRH20012-MGfa-35H* (01/26)

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

Commonwealth of Kentucky NASCIO Recognition Awards Nomination Category: Data, Information and Knowledge Management. ekasper

GENERAL ASSEMBLY OF NORTH CAROLINA SESSION 2017 SESSION LAW HOUSE BILL 243

ARKANSAS DEPARTMENT OF HEALTH

OFFICIAL POLICY. Policy Statement

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

PRESCRIBING GUIDELINES

NEW MEXICO DEPARTMENT OF HEALTH Administrative Manual ADMINISTRATION

Our Journey to Addressing the PA PDMP Program. Dean Parry, RPh AVP Clinical Informatics, Care Support Services Geisinger Health System

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Medicare Advantage Outreach and Education Bulletin

OPIOID. Opioid Legislation FAQs NEED TO KNOW

THE FDA DRUG APPROVAL PROCESS Under the Federal Food, Drug, and Cosmetic (FD&C) Act, FDA is responsible for ensuring that all new drugs are safe and

PRODUCTS: All products containing ephedrine (EPH) and pseudoephedrine (PSE). (IC )

An Update on Kentucky All Schedule Prescription Electronic Reporting (KASPER)

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

The Controlled Substances Act: Regulatory Requirements

Opioid Management of Chronic (Non- Cancer) Pain

& CONSUMES 80% 5% OF THE WORLD S POPULATION 5/19/2017. New Naloxone Regulations & the Importance of Using PRESCRIPTION DRUG ABUSE EPIDEMIC

ASPMN Conference Baltimore, Maryland

Project Update: Comparing South Dakota Prescription Drug Monitoring Program Law Enforcement Profile Requests to Criminal History Data

Good Samaritan and Naloxone Bill Status Report Carryover 2015 and Special Sessions

LUNCH AND LEARN. January 8, CE Activity Information & Accreditation

GILMER COUNTY SCHOOLS Policy No POLICY MANUAL

Technical Assistance Guide No Recommended PDMP Reports to Support Licensing/Regulatory Boards and Law Enforcement Investigations

Prescription Monitoring Program Center of Excellence at Brandeis. Drug-Related Deaths in Virginia: Medical Examiner Use of PMP Data

Preparing Your Pharmacy for a DEA Inspection

UTAH S CONTROLLED SUBSTANCE DATABASE PROGRAM (CSDB)

California. Prescribing and Dispensing Profile. Research current through November 2015.

October 20, 2016 Scott K. Proescholdbell, MPH. Opioid Overdose and North Carolina s Public Health and Prevention Strategies

Presentation Overview

Statement Of. The National Association of Chain Drug Stores. For. United States Senate Caucus on International Narcotics Control.

Confirm Limit--Level of detectable drugs in urine to confirm a positive test.

Referred to Committee on Health and Human Services. SUMMARY Establishes an opioid overdose prevention policy for Nevada.

Prescribing Controlled Substances and the PDMP

WikiLeaks Document Release

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

2017 NASCSA Conference

C. No employee shall report to work or remain on duty while having a detectable blood alcohol concentration.

Patient and Family Agreement on Opioids

Use of Controlled Substances in Research.

Arkansas Department of Health

Transcription:

Controlled Substance Prescribing and Diversion Pamela Polk, R. Ph., Inspector DHEC Bureau of Drug Control

In 2010, approximately 38,329 unintentional drug overdose deaths occurred in the United States, one death every 14 minutes. Of this number, 22,134 of the deaths were attributed to prescription drugs. (75.2%) 16,651 were attributed to opioid overdoses. Prescription drug abuse is the fastest growing drug problem in the United States. Source: CDC Drug Overdose Deaths in the United States, 2010 (October 2012) U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control

Drug-Induced Deaths vs. Other Injury Deaths (1999 2009) Causes of death attributable to drugs include accidental or intentional poisonings by drugs and deaths from medical conditions resulting from chronic drug use. Drug-induced causes exclude accidents, homicides, and other causes indirectly related to drug use. Not all injury cause categories are mutually exclusive. Source: National Center for Health Statistics, Centers for Disease Control and Prevention. National Vital Statistics Reports Deaths: Final Data for the years 1999 to 2009 (January 2012).

New Initiates 2011 12 years and older Note: Numbers refer to persons who used a specific drug for the first time in the past year, regardless of whether initiation of other drug use occurred prior to that year. Source: 2011 NSDUH

Top Five Prescription Drugs Sold in the U.S. (2006-2011) 160,000,000 140,000,000 120,000,000 100,000,000 80,000,000 Source: IMS Health (By Number of Prescriptions Sold)) Hydrocodone/Apap Lipitor Amoxicillin Lisinopril Simvastatin Levothyroxine Azithromycin Amlodipine besylate 60,000,000 40,000,000 20,000,000 0 2006 2007 2008 2009 2010 2011

Poisoning Deaths: Opioid Analgesics Poisoning Deaths Source: CDC/NCHS, National Vital Statistics System

ED Admissions Due to Non-medical use of Pharmaceuticals SAMHSA 2011 Data 2004 2011 Total 535,477 1,244,872 Adderall 2,303 17,272 Hydrocodone 39,846 82,480 Oxycodone 41,701 151,218 Alprazolam 46,528 123,744

National Drug Control Policy and Prescription Drug Abuse: Facts and Fallacies Laxmaiah Manchikanti, M.D., 2007 Parallel to opioid supply and nonmedical prescription drug use, the epidemic of medical drug use is also escalating with Americans using 80% of world s supply of all opioids and 99% of Hydrocodone. The population of the United States comprises 4% of the world s population.

Presentation Objective Role of DHEC Drug Control Requirements of a valid controlled substance prescription Practitioner inspections and common concerns Controlled Substance Laws Common methods of diversion

Role of DHEC Drug Control SC Controlled Substance Act tasks DHEC with maintaining accountability of controlled substances in possession of those persons legally authorized to possess them. SC Code Sec 44-53-480(b)

Role of DHEC Drug Control Our goal is to achieve and maintain compliance with applicable laws and regulations through education.

Regulatory Duties Duties of an Inspector Registrant inspections Accountability audits Education Law Enforcement Duties Investigate and arrest for violations of SC Controlled Substance Act

SC Code of Laws References: Title 44 (Health), Chapter 53 (Poisons, Drugs, and Other Controlled Substances) 44-53-*** SC Code of Regulations Chapter 61-4 (Controlled Substances)

Valid controlled substance prescriptions SC 44-53-360. Prescriptions (c) No controlled substances included in any schedule may be distributed or dispensed for other than a medical purpose. No practitioner may dispense a controlled substance outside of a bona fide practitioner-patient relationship.

Valid controlled substance prescriptions (cont.) SC 44-53-360. Prescriptions (h) A prescription, in order to be effective in legalizing the possession of a controlled substance and eliminating the need for registration of the recipient, must be issued for legitimate medical purposes. The responsibility for the proper prescribing and dispensing of controlled substances is upon the prescribing practitioner, but a corresponding liability rests with the pharmacist who fills and ultimately dispenses the prescription.

Usual Course of Professional Practice Reg. 61-4 Section 1002 (a) A prescription for a controlled substance to be effective shall be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his or her professional practice.

Usual Course of Practice Reg. 61-4 Section 1002 (c) A prescription may not be issued for the dispensing of narcotic drugs listed in any schedule to a narcotic drug dependent person for the purpose of continuing his or her dependence upon such drugs

Prescribing for Family Members Reg. 61-4 Section 1204 A practitioner cannot usually acquire a valid practitioner-patient relationship with a member of his or her immediate family due to the likelihood of the loss or vitiation of the objectivity required in making the necessary medical decisions in order to properly prescribe controlled substances (fiancé, close personal friend, paramour, etc)

Prescribing for Family Members Reg. 61-4 Section 1204 In the event of a bona fide emergency situation, where great detriment to the health or safety of a patient may be involved, a practitioner may administer, dispense, or prescribe limited amounts of controlled substances to any person until such time as another objective practitioner can be contacted.

Prescribing for Family Members SC Medical Board Examiner (Winter 1999) The board feels that prescribing controlled substances for family members is outside the scope of good medical practice in South Carolina, except for a bona fide emergency situation where the health and safety of an individual may be at great detriment.

Requirements of a Valid Controlled Substance Prescription (1) Valid practitioner-patient relationship (2) Treatment of a legitimate medical condition (3) Practitioner acting in the usual course of professional practice (4) Properly licensed and registered practitioner- LLR license, prescriptive authority, DHEC and DEA controlled substance registrations

Violation SC 44-53-380 Prohibited acts B; penalties (a) It shall be unlawful for any person: (1) Who is subject to the requirements of Sections 44-53-280 to 44-53-360 to distribute or dispense a controlled substance in violation of Section 44-53-360;

SC 44-53-380 cont. Penalty (b) Any person who violates this section is punishable by a civil fine of not more than one thousand dollars; provided that, if the violation is prosecuted by an information or indictment which alleges the violation was committed knowingly or intentionally, such a person shall be deemed guilty of a felony and, upon conviction, shall be imprisoned for not more than five years, or fined not more than ten thousand dollars

Controlled Substance Inventory Must be conducted on May 1 of each year Must indicate time of day Must be readily retrievable for 2 years Must have the name, address, and DEA number of the registrant

Controlled Substance Inventory Must be maintained at the registered location Must include all controlled substances on hand, including samples

Receipt Records Must be noted with date received Must be readily retrievable for 2 years Controlled substance records must be kept separate from non-controlled substance records, and CII records should be separated from CIII, CIV, and CV records

Dispensing Records Controlled substance dispensing records must be kept separate from patient chart Record must include the following information: Drug name and strength Date dispensed or administered Patient name and address Quantity dispensed or administered RN or dispenser s signature or initials Practitioner s initials Must report dispensations to SC Prescription Monitoring Program

Security Controlled substances should be stored in a securely locked and substantially constructed cabinet Registrants should report any theft to DHEC Bureau of Drug Control Suggestions: Limit access to the locked cabinet Do a weekly count and denote on dispensing log Have a witness to all wastage and have both persons sign

Additional Key Items Keep all prescription blanks in a secure place Power of attorney Documentation of all authorized controlled substance prescriptions in patient s medical record

Some Common Problems Failure to conduct May 1 inventory Unable to locate receipt records Incomplete dispensing records Post-dated prescriptions (all prescriptions must be dated on the date written)

Some Common Problems Pre-signed prescription blank (violation of SC Code 44-53-395(A)(1)) Controlled substances not stored in a secure location Prescriptions issued outside of valid patient/practitioner relationship (44-53-380) Stamped or electronic signature (SC Reg 1003)

Some Common Problems Prescriptions issued outside of usual course of professional practice (44-53-380) Excessive quantity (cannot exceed thirty-one days supply for C-II) Faxed prescriptions for C-II that are not issued to terminal, LTCF, or home-infusion patients

Other Agencies Drug Enforcement Administration (DEA) SC LLR Board of Nursing Board of Pharmacy Board of Medical Examiner

Commonly Diverted and Abused Controlled Pharmaceuticals Schedule II Hydrocodone Products Most commonly diverted and abused licit drug Most often cited brands Norco,Lortab, Lorcet, Vicodin Oxycodone Oxycodone is the drug of choice in most areas Methadone

Common Diversion Methods Legally obtaining drugs for medical condition Stealing drugs from sick family members or befriending a patient who gets lots of C/S Lying to physicians regarding pain level Calling physicians after-hours and claiming to be a patient of his/her partner Going to multiple practitioners and/or different pharmacies Altering prescriptions that were legally issued

Common Diversion Methods (cont d.) Using stolen prescription blanks Generating Rx blanks on computer or making photocopies Calling in their own prescriptions for controlled substances Diversions by employees or pharmacists (for personal use/profit) [Reg 61-4-410] Armed robberies and/or break-ins of pharmacies, drug wholesalers or physicians offices

Suggestions: patients requesting controlled substances Don t call in controlled substance unless you have valid practitioner-patient relationship and can verify legitimate medical need Ask the patient to come to office for evaluation Contact the pharmacy Advise the patient that state law requires pharmacy to document picture identification before dispensing.

Doctor Shopping Ask direct questions about other health care providers that patient may be seeing and other medications patient is receiving; document responses. Written sole-provider contracts can be very useful in most settings. Use resources that are available.

Applicable Laws 44-53-390(A)(3): Illegal to obtain controlled substance by fraud, forgery, deception, or subterfuge. 44-53-395(A) (3): Illegal to withhold information that a medication of like therapeutic use was obtained from another practitioner during a concurrent time period.

Prescription Forgery Commonly due to stolen or photocopied prescription blanks. Increase in scanned or computer-generated forgeries. Large number of fraudulent telephoned prescriptions for C-III and C-IV, especially alprazolam and formerly hydrocodone, now tramadol.

Suggestions to prevent forgeries Use prescription blanks that are difficult to photocopy or scan into computer. Always secure prescription pads/paper. Do not leave prescription blanks in exam rooms. Never sign blank prescriptions!

Altered Prescriptions Altered quantity Altered refills Altered dates, including do not fill until dates Altered medication strengths Medications added at bottom of prescription

Suggestions to prevent prescription alteration Write out quantity in numerals and spell out alphabetically. Line or zero out refills if none authorized. Line out unused portions of prescription or write total number of rx on script.

Diversion of Controlled Substances by an Employee Do not say anything to the employee; obtain as much information as possible without causing any suspicion Contact your local law enforcement agency or SC DHEC Bureau of Drug Control Reg 61-4-406(a) - prohibits any registrant from employing a person with a felony record related to controlled substances to have access to controlled substances

When to Contact Drug Control Suspicion of forged, altered, or fraudulent controlled substance prescriptions Deception or misrepresentation made by patients to obtain controls Suspected doctor-shopping activity

Requires pharmacist or practitioner dispensers to electronically or manually (waiver) submit information regarding each controlled substance (CII, CIII & CIV) prescription dispensed.

A SCRIPTS report provides information for scheduled prescriptions a patient has had filled for the specified time period, as well as the prescriber who prescribed them and the dispenser who dispensed them. The report should be used to supplement a patient evaluation, to confirm a patient s drug history or document compliance with a therapeutic regimen. SCRIPTS is updated daily SCRIPTS includes CII, CIII, & CIV Rxs

Dispenser does not include: Hospital pharmacies that distribute controlled substances for inpatients, or dispenses controlled substances at time of discharge; however, hospital outpatient pharmacies must report Hospital emergency rooms/departments (less than a 48- hour supply) Practitioners who administer controlled substances VA inpatient or outpatient pharmacies Most long-term care and assisted living dispensers Wholesale distributors 48

PMP REPORTS- Who may receive them? A practitioner or pharmacist for providing treatment to a bona fide patient A state, federal, or local law enforcement, or prosecutorial official for a specific drug related investigation involving a designated person LLR Boards DHHS regarding a Medicaid recipient Subpoena by a grand jury ****************************************** REMINDER: Reports cannot be shared with anyone (raw data). 49

Visit us at: www.dhec.sc.gov/scripts Christie Frick, RPh Tracie M. Paschall, CPhT DHEC- BDC Prescription Monitoring Program 2600 Bull Street Columbia, SC 29201 Phone 803.896.0688 Fax 803.896.0686 OR SCRIPTS@DHEC.SC.GOV